Performance analysis of multi-hop framed ALOHA systems with virtual antenna arrays

We consider a multi-hop virtual multiple-input-multiple-output system, which uses the framed ALOHA technique to select the radio resource at each hop. In this scenario, the source, destination and relaying nodes cooperate with neighboring devices to exploit spatial diversity by means of the concept of virtual antenna array. We investigate both the optimum number of slots per frame in the slotted structure and once the source-destination distance is fixed, the impact of the number of hops on the system performance. A comparison with deterministic, centralized re-use strategies is also presented. Outage probability, average throughput, and energy efficiency are the metrics used to evaluate the performance. Two approximated mathematical expressions are given for the outage probability, which represent lower bounds for the exact metric derived in the paper

Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia

Background: Few studies evaluated the clinical outcomes of Community Acquired Pneumonia (CAP), Hospital-Acquired Pneumonia (HAP) and Health Care-Associated Pneumonia (HCAP) in relation to the adherence of antibiotic treatment to the guidelines of the Infectious Diseases Society of America (IDSA) and the American Thoracic Society (ATS) in hospitalized elderly people (65 years or older). Methods: Data were obtained from REPOSI, a prospective registry held in 87 Italian internal medicine and geriatric wards. Patients with a diagnosis of pneumonia (ICD-9 480-487) or prescribed with an antibiotic for pneumonia as indication were selected. The empirical antibiotic regimen was defined to be adherent to guidelines if concordant with the treatment regimens recommended by IDSA/ATS for CAP, HAP, and HCAP. Outcomes were assessed by logistic regression models. Results: A diagnosis of pneumonia was made in 317 patients. Only 38.8% of them received an empirical antibiotic regimen that was adherent to guidelines. However, no significant association was found between adherence to guidelines and outcomes. Having HAP, older age, and higher CIRS severity index were the main factors associated with in-hospital mortality. Conclusions: The adherence to antibiotic treatment guidelines was poor, particularly for HAP and HCAP, suggesting the need for more adherence to the optimal management of antibiotics in the elderly with pneumonia

Altered plasma protein profiles in genetic FTD – a GENFI study

© The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.Background: Plasma biomarkers reflecting the pathology of frontotemporal dementia would add significant value to clinical practice, to the design and implementation of treatment trials as well as our understanding of disease mechanisms. The aim of this study was to explore the levels of multiple plasma proteins in individuals from families with genetic frontotemporal dementia. Methods: Blood samples from 693 participants in the GENetic Frontotemporal Dementia Initiative study were analysed using a multiplexed antibody array targeting 158 proteins. Results: We found 13 elevated proteins in symptomatic mutation carriers, when comparing plasma levels from people diagnosed with genetic FTD to healthy non-mutation controls and 10 proteins that were elevated compared to presymptomatic mutation carriers. Conclusion: We identified plasma proteins with altered levels in symptomatic mutation carriers compared to non-carrier controls as well as to presymptomatic mutation carriers. Further investigations are needed to elucidate their potential as fluid biomarkers of the disease process.Open access funding provided by Karolinska Institute. C.G. received funding from EU Joint Programme—Neurodegenerative Disease Research -Prefrontals Vetenskapsrådet Dnr 529–2014-7504, Vetenskapsrådet 2015–02926, Vetenskapsrådet 2018–02754, the Swedish FTD Inititative-Schörling Foundation, Alzheimer Foundation, Brain Foundation, Dementia Foundation and Region Stockholm ALF-project. PN received funding from KTH Center for Applied Precision Medicine (KCAP) funded by the Erling-Persson Family Foundation, the Swedish FTD Inititative-Schörling Foundation and Åhlén foundation. D.G. received support from the EU Joint Programme—Neurodegenerative Disease Research and the Italian Ministry of Health (PreFrontALS) grant 733051042. E.F. has received funding from a Canadian Institute of Health Research grant #327387. F.M. received funding from the Tau Consortium and the Center for Networked Biomedical Research on Neurodegenerative Disease. J.B.R. has received funding from the Welcome Trust (103838) and is supported by the Cambridge University Centre for Frontotemporal Dementia, the Medical Research Council (SUAG/051 G101400) and the National Institute for Health Research Cambridge Biomedical Research Centre (BRC-1215–20014). J.C.V.S. was supported by the Dioraphte Foundation grant 09–02-03–00, Association for Frontotemporal Dementias Research Grant 2009, Netherlands Organization for Scientific Research grant HCMI 056–13-018, ZonMw Memorabel (Deltaplan Dementie, project number 733 051 042), Alzheimer Nederland and the Bluefield Project. J.D.R. is supported by the Bluefield Project and the National Institute for Health and Care Research University College London Hospitals Biomedical Research Centre, and has received funding from an MRC Clinician Scientist Fellowship (MR/M008525/1) and a Miriam Marks Brain Research UK Senior Fellowship. M.M. has received funding from a Canadian Institute of Health Research operating grant and the Weston Brain Institute and Ontario Brain Institute. M.O. has received funding from Germany’s Federal Ministry of Education and Research (BMBF). R.S-V. is supported by Alzheimer’s Research UK Clinical Research Training Fellowship (ARUK-CRF2017B-2) and has received funding from Fundació Marató de TV3, Spain (grant no. 20143810). R.V. has received funding from the Mady Browaeys Fund for Research into Frontotemporal Dementia. This work was also supported by the EU Joint Programme—Neurodegenerative Disease Research GENFI-PROX grant [2019–02248; to J.D.R., M.O., B.B., C.G., J.C.V.S. and M.S.info:eu-repo/semantics/publishedVersio

Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study

Background Huntington's disease is caused by a CAG repeat expansion in the huntingtin gene, HTT. Age at onset has been used as a quantitative phenotype in genetic analysis looking for Huntington's disease modifiers, but is hard to define and not always available. Therefore, we aimed to generate a novel measure of disease progression and to identify genetic markers associated with this progression measure. Methods We generated a progression score on the basis of principal component analysis of prospectively acquired longitudinal changes in motor, cognitive, and imaging measures in the 218 indivduals in the TRACK-HD cohort of Huntington's disease gene mutation carriers (data collected 2008–11). We generated a parallel progression score using data from 1773 previously genotyped participants from the European Huntington's Disease Network REGISTRY study of Huntington's disease mutation carriers (data collected 2003–13). We did a genome-wide association analyses in terms of progression for 216 TRACK-HD participants and 1773 REGISTRY participants, then a meta-analysis of these results was undertaken. Findings Longitudinal motor, cognitive, and imaging scores were correlated with each other in TRACK-HD participants, justifying use of a single, cross-domain measure of disease progression in both studies. The TRACK-HD and REGISTRY progression measures were correlated with each other (r=0·674), and with age at onset (TRACK-HD, r=0·315; REGISTRY, r=0·234). The meta-analysis of progression in TRACK-HD and REGISTRY gave a genome-wide significant signal (p=1·12 × 10−10) on chromosome 5 spanning three genes: MSH3, DHFR, and MTRNR2L2. The genes in this locus were associated with progression in TRACK-HD (MSH3 p=2·94 × 10−8 DHFR p=8·37 × 10−7 MTRNR2L2 p=2·15 × 10−9) and to a lesser extent in REGISTRY (MSH3 p=9·36 × 10−4 DHFR p=8·45 × 10−4 MTRNR2L2 p=1·20 × 10−3). The lead single nucleotide polymorphism (SNP) in TRACK-HD (rs557874766) was genome-wide significant in the meta-analysis (p=1·58 × 10−8), and encodes an aminoacid change (Pro67Ala) in MSH3. In TRACK-HD, each copy of the minor allele at this SNP was associated with a 0·4 units per year (95% CI 0·16–0·66) reduction in the rate of change of the Unified Huntington's Disease Rating Scale (UHDRS) Total Motor Score, and a reduction of 0·12 units per year (95% CI 0·06–0·18) in the rate of change of UHDRS Total Functional Capacity score. These associations remained significant after adjusting for age of onset. Interpretation The multidomain progression measure in TRACK-HD was associated with a functional variant that was genome-wide significant in our meta-analysis. The association in only 216 participants implies that the progression measure is a sensitive reflection of disease burden, that the effect size at this locus is large, or both. Knockout of Msh3 reduces somatic expansion in Huntington's disease mouse models, suggesting this mechanism as an area for future therapeutic investigation

LoRaWANSim:a flexible simulator for LoRaWAN networks

Abstract Among the low power wide area network communication protocols for large scale Internet of Things, LoRaWAN is considered one of the most promising, owing to its flexibility and energy-saving capabilities. For these reasons, during recent years, the scientific community has invested efforts into assessing the fundamental performance limits and understanding the trade-offs between the parameters and performance of LoRaWAN communication for different application scenarios. However, this task cannot be effectively accomplished utilizing only analytical methods, and precise network simulators are needed. To that end, this paper presents LoRaWANSim, a LoRaWAN simulator implemented in MATLAB, developed to characterize the behavior of LoRaWAN networks, accounting for physical, medium access control and network aspects. In particular, since many simulators described in the literature are deployed for specific research purposes, they are usually oversimplified and hold a number of assumptions affecting the accuracy of their results. In contrast, our simulator has been developed for the sake of completeness and it is oriented towards an accurate representation of the LoRaWAN at the different layers. After a detailed description of the simulator, we report a validation of the simulator itself and we then conclude by presenting some results of its use revealing notable and non-intuitive trade-offs present in LoRaWAN. Such simulator will be made available via open access to the research community

Low-Power Wide-Area Networks:comparison of LoRaWAN and NB-IoT performance

Abstract Low Power Wide Area Networks (LPWANs) have become an important enabler for the Internet of Things (IoT) connectivity. Application domains like smart cities, smart agriculture, intelligent logistics and transportation, require communication technologies that combine long transmission ranges and energy efficiency. Recent and future trends make Long Range Wide Area Network (LoRaWAN) and Narrowband-IoT (NB-IoT) the most prospective drivers of the IoT business. In this paper, after discussing the main features of the two technologies, we carry out a fair quantitative comparison between the two, investigating different performance indicators, in order to guide designers in the selection of the most appropriate technology, depending on the application requirements

Data collection from LoRaWAN sensor network by UAV gateway:design, empirical results and dataset

Abstract Collecting data from Internet-of-Things (IoT) devices, especially the variety of sensors dispersed in the environment, is an increasingly important and difficult task. Several long-range radio-access technologies, such as low-power wide-area networks (LPWAN) and specifically LoRaWAN, have been proposed to address this challenge. However, until now, the key focus of the related studies has been on static terrestrial LPWAN deployments. In this study, we depart from this vision and investigate the practical feasibility and performance of a LoRaWAN gateway (GW) on a flying platform, specifically — an unmanned aerial vehicle (UAV). The key contributions of this study are (i) the design and field-testing of a packet-sniffer-based mobile LoRaWAN GW prototype, allowing collection of the data from LoRaWAN networks, including the already deployed ones; (ii) the open-publication of the data collected during our experimental campaign in the 426 LoRaWAN sensor node network of the University of Oulu illustrating the performance of different drone trajectories; (iii) the initial results of the system’s performance analysis, revealing some interesting trends and setting goals for further studies, and pinpointing the lessons learned during the experimental campaign. Our empirical findings suggest that the Travelling Salesman Problem (TSP) trajectory is the most effective moving trajectory for the number of packets collected and the average energy consumed per packet collected

Unmanned aerial base stations for NB-IoT:trajectory design and performance analysis

Abstract In this paper, we consider a NarrowBand-Internet of Things (NB-IoT) network where an Unmanned Aerial Vehicle (UAV) is employed to gather data from IoT devices deployed in a given area. It is well known that UAVs may fly over the terrestrial plane, where and when needed, acting as Unmanned Aerial Base Stations (UABs). In order to serve as many ground IoT devices as possible, a proper trajectory design is fundamental. As we show in the paper, the optimization of the UAV speed and the radio parameters are also essential. Specifically, this paper studies a cluster-based scenario, where IoT devices are deployed according to a Thomas process, and applies a Traveling Salesman Problem approach to design the UAB trajectory. Notably, our model considers the protocol constraints on the number of resource units available on the UAB’s NPUSCH, and the data rate that it can provide to IoT devices. Our results reveal the impact of different design parameters, such as UAB speed and NPRACH periodicity on the network throughput and the number of requests served

Nicotine Fast Dissolving Films Made of Maltodextrins: A Feasibility Study

This work aimed to develop a fast-dissolving film made of low dextrose equivalent maltodextrins (MDX) containing nicotine hydrogen tartrate salt (NHT). Particular attention was given to the selection of the suitable taste-masking agent (TMA) and the characterisation of the ductility and flexibility under different mechanical stresses. MDX with two different dextrose equivalents (DEs), namely DE 6 and DE 12, were selected in order to evaluate the effect of polymer molecular weight on film tensile properties. The bitterness and astringency intensity of NHT and the suppression effect of several TMA were evaluated by a Taste-Sensing System. The films were characterised in term of NHT content, tensile properties, disintegration time and drug dissolution test. As expected, placebo films made of MDX DE 6 appeared stiffer and less ductile than film prepared using MDX DE 12. The films disintegrated within 10 s. Among the tested TMA, the milk and mint flavours resulted particularly suitable to mask the taste of NHT. The addition of NHT and taste-masking agents affected film tensile properties; however, the effect of the addition of these components can be counterweighted by modulating the glycerine content and/or the MDX molecular weight. The feasibility of NHT loaded fast-dissolving films was demonstrated